ストックスクリーナーアプリを入手
328.20
0.15%
-0.49
アフターアワーズ：
328.20
前日終値:
$328.69
開ける：
$328.12
24時間の取引高:
315.23K
Relative Volume:
0.57
時価総額：
$12.91B
収益：
$1.40B
当期純損益:
$177.69M
株価収益率:
72.56
EPS:
4.5234
ネットキャッシュフロー:
$174.93M
1週間 パフォーマンス:
+0.51%
1か月 パフォーマンス:
-0.51%
6か月 パフォーマンス:
+10.89%
1年 パフォーマンス:
+22.22%
1日の値動き範囲:
$327.81
$329.65
1週間の範囲:
$325.13
$329.67
52週間の値動き範囲:
$221.26
$362.41
Penumbra Inc Stock (PEN) Company Profile
Compare PEN vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PEN
Penumbra Inc
|
328.20 | 12.93B | 1.40B | 177.69M | 174.93M | 4.5234 |
ABT
Abbott Laboratories
|
86.67 | 152.25B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
313.00 | 121.33B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
77.60 | 100.91B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.64 | 85.88B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.54 | 49.39B | 6.30B | 1.07B | 1.09B | 1.8406 |
Penumbra Inc Stock (PEN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-18 | アップグレード | JP Morgan | Neutral → Overweight |
| 2025-12-11 | アップグレード | Citigroup | Neutral → Buy |
| 2025-11-18 | 開始されました | Wells Fargo | Underweight |
| 2025-10-08 | アップグレード | Needham | Hold → Buy |
| 2025-09-02 | 開始されました | Evercore ISI | Outperform |
| 2025-03-14 | 開始されました | BofA Securities | Buy |
| 2025-01-21 | 開始されました | UBS | Buy |
| 2024-12-17 | 開始されました | Oppenheimer | Outperform |
| 2024-12-11 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-09-18 | 開始されました | Stifel | Buy |
| 2024-09-03 | 開始されました | Leerink Partners | Outperform |
| 2024-07-31 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-07-31 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2024-02-23 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2023-09-06 | 開始されました | Morgan Stanley | Equal-Weight |
| 2023-07-19 | 開始されました | Robert W. Baird | Outperform |
| 2023-03-29 | ダウングレード | Needham | Buy → Hold |
| 2023-01-30 | 開始されました | Piper Sandler | Overweight |
| 2022-11-04 | アップグレード | Citigroup | Neutral → Buy |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-10-05 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-09-09 | アップグレード | Needham | Hold → Buy |
| 2022-07-18 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-04-19 | 開始されました | Deutsche Bank | Buy |
| 2022-03-08 | 開始されました | Needham | Hold |
| 2021-09-16 | 開始されました | Truist | Buy |
| 2021-06-04 | アップグレード | BTIG Research | Neutral → Buy |
| 2020-12-16 | ダウングレード | BTIG Research | Buy → Neutral |
| 2020-10-07 | 再開されました | Canaccord Genuity | Buy |
| 2020-09-29 | 開始されました | BTIG Research | Buy |
| 2020-09-08 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2019-06-13 | 繰り返されました | BofA/Merrill | Buy |
| 2019-05-30 | アップグレード | JP Morgan | Neutral → Overweight |
| 2019-05-21 | 開始されました | William Blair | Outperform |
| 2018-10-29 | 再開されました | BofA/Merrill | Buy |
| 2018-10-08 | 開始されました | RBC Capital Mkts | Outperform |
| 2018-02-21 | 開始されました | William Blair | Outperform |
| 2018-01-02 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2015-11-30 | 繰り返されました | Canaccord Genuity | Buy |
| 2015-10-13 | 開始されました | Wells Fargo | Outperform |
すべてを表示
Penumbra Inc (PEN) 最新ニュース
Penumbra, Inc. (PEN) Stock Analysis: A Healthcare Giant With A 10.55% Upside Potential - DirectorsTalk Interviews
Water Island Event-Driven Fund's Penumbra Inc(PEN) Holding History - GuruFocus
Penumbra stock hits 52-week high at $328.69 By Investing.com - Investing.com Australia
Penumbra stock hits 52-week high at $328.69 - Investing.com
Penumbra (PEN) CEO-linked trust donates 77,000 shares in charitable stock gift - Stock Titan
Peripheral Embolization Coils Market is experiencing boost - openPR.com
PEN Stock Price, Quote & Chart | PENUMBRA INC (NYSE:PEN) - ChartMill
(PEN) Movement as an Input in Quant Signal Sets - Stock Traders Daily
ServisFirst Gets Axed by Champlain — a Minor Position in a Major Drawdown - The Motley Fool
HBK INVESTMENTS L P's Penumbra Inc(PEN) Holding History - GuruFocus
120,815 Shares in Penumbra, Inc. $PEN Purchased by Stephens Investment Management Group LLC - MarketBeat
Thrivent Financial for Lutherans Sells 72,330 Shares of Penumbra, Inc. $PEN - MarketBeat
Penumbra, Inc. (NYSE:PEN) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Penumbra, Inc. (PEN) Stock Analysis: Navigating a 12.76% Upside in the Medical Devices Sector - DirectorsTalk Interviews
Penumbra, Inc. Reports Third Quarter 2025 Financial Results - Quantisnow
Penumbra Shareholders Approve Merger with Boston Scientific - The Globe and Mail
Penumbra revenue up 15.6% to USD 374.8M in Q1 2026 - Medical Buyer
PEN Maintained by Citigroup -- Price Target Lowered to $350 - GuruFocus
Citi Maintains Penumbra(PEN.US) With Hold Rating, Cuts Target Price to $350 - Moomoo
Penumbra Is Maintained at Outperform by Evercore ISI Group - Moomoo
Liquidity Mapping Around (PEN) Price Events - Stock Traders Daily
PEN Maintained by Evercore ISI Group -- Price Target Lowered to $335 - GuruFocus
Penumbra Is a 'Strong' Strategic Fit for Boston Scientific, RBC Says - Moomoo
Penumbra shareholders approve merger with Boston Scientific By Investing.com - Investing.com Australia
Penumbra, Inc. Q1 2026 Financial Results: Earnings, Comprehensive Income, and Stockholders’ Equity Highlights - Minichart
Penumbra IncStockholders approve merger with Boston ScientificSEC filing - marketscreener.com
Penumbra shareholders approve merger with Boston Scientific - Investing.com
Penumbra (NYSE: PEN) shareholders approve Merger Proposal; closing conditions remain - Stock Titan
Penumbra (NYSE: PEN) investors back merger, await antitrust approvals - Stock Titan
Evercore Maintains Penumbra(PEN.US) With Buy Rating, Cuts Target Price to $335 - Moomoo
Penumbra: Q1 Earnings Snapshot - theheraldreview.com
Assessing Penumbra (PEN) Valuation As Growth Expectations Meet A Premium P/E Multiple - Yahoo Finance
Penumbra Shareholder Notice - TMX Newsfile
MSN Money - MSN
Penumbra (PEN) Misses Q1 Earnings Estimates - Yahoo Finance
[10-Q] Penumbra Inc Quarterly Earnings Report - Stock Titan
Earnings Flash (PEN) Penumbra, Inc. Reports Q1 Revenue $374.8M, vs. FactSet Est of $371.3M - marketscreener.com
Penumbra (NYSE: PEN) posts $374.8M Q1 2026 revenue as Boston Scientific deal looms - Stock Titan
Penumbra posts $32.6M profit as Boston Scientific deal halts outlook - Stock Titan
Penumbra, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
PEN Technical Analysis | Trend, Signals & Chart Patterns | PENUMBRA INC (NYSE:PEN) - ChartMill
Penumbra earnings in focus as Boston Scientific deal looms By Investing.com - Investing.com South Africa
Penumbra earnings in focus as Boston Scientific deal looms - Investing.com
Penumbra, Inc. (PEN) Stock Analysis: A 12.44% Potential Upside in the Thriving Medical Devices Sector - DirectorsTalk Interviews
Vanguard Group Inc. Cuts Stock Position in Penumbra, Inc. $PEN - MarketBeat
Inside Boston Scientific's $15 billion offer for Alameda's largest employer - The Business Journals
Penumbra Inc (PEN) 財務データ
収益
当期純利益
現金流量
EPS
1.27%
2.05%
大文字化:
|
ボリューム (24 時間):